Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of LJP 394 in Lupus Patients With History of Renal Disease (ASPEN)
This study has been terminated.
( Interim efficacy analysis indicated it would be futile to continue study. )
Study NCT00089804   Information provided by La Jolla Pharmaceutical Company
First Received: August 13, 2004   Last Updated: March 30, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Lupus Erythematosus, Systemic
Lupus Nephritis
Additional conditions recognized in this trial
Kidney Diseases
Nephritis
More general conditions related to this trial
Autoimmune Diseases
Connective Tissue Diseases
Glomerulonephritis
Immune System Diseases
Urologic Diseases
Interventions listed in this trial
abetimus sodium (LJP 394)
Phosphate-buffered saline
Sponsors listed in this trial
La Jolla Pharmaceutical Company


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services